Publications by authors named "Veerle Huyst"

Introduction: Autistic individuals identify with a wider range of sexual orientations than non-autistic individuals, including higher rates of bisexual orientation in autistic men. Gay, bisexual and other men who have sex with men are at greater risk for HIV. Prevalence data of autistic traits in people living with HIV or using Pre-Exposure Prophylaxis (PrEP) for HIV are lacking so far.

View Article and Find Full Text PDF

Objectives: To investigate the burden and outcome of HIV infection and other morbidities amongst a Mozambican hospital staff.

Methods: Within an occupational health service set up in April 2008 in the provincial hospital of Tete, Mozambique, we offered to all staff members an initial clinical, laboratory and radiological screening and followed them up prospectively until April 2010.

Results: A total of 47.

View Article and Find Full Text PDF

In a retrospective study of 648 persons with HIV infection in Cambodia, we determined the sensitivity, specificity, and accuracy of the 2003 World Health Organization (WHO) criteria to start antiretroviral treatment based on clinical criteria alone or based on a combination of clinical symptoms and the total lymphocyte count. As a reference test, we used the 2003 WHO criteria, including the CD4 count. The 2003 WHO clinical criteria had a sensitivity of 96%, a specificity of 57%, and an accuracy of 89% to identify patients who need highly active antiretroviral therapy (HAART).

View Article and Find Full Text PDF

Telemedicine is a way to support health care delivery in remote areas. With our telemedicine project the Institute of Tropical Medicine, Antwerp, Belgium, intended to facilitate the introduction of antiretroviral therapy (ART) for patients affected by Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) in developing countries, providing training, distance support and education to healthcare providers working in those settings.

View Article and Find Full Text PDF

The introduction of highly active antiretroviral therapy (HAART) has changed the natural history of AIDS-associated Kaposi's sarcoma (KS). Although the use of HAART remains limited in low-resource settings, there are global initiatives to make these drugs available to several millions of HIV-infected persons. While there are multiple reports of KS regression during HAART with or without chemotherapy, there is little documentation on KS management in resource-limited settings.

View Article and Find Full Text PDF